0001209191-22-011299.txt : 20220218
0001209191-22-011299.hdr.sgml : 20220218
20220218163311
ACCESSION NUMBER: 0001209191-22-011299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220216
FILED AS OF DATE: 20220218
DATE AS OF CHANGE: 20220218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luthringer Remy
CENTRAL INDEX KEY: 0001610384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 22653338
MAIL ADDRESS:
STREET 1: C/O MINERVA NEUROSCIENCES, INC.
STREET 2: 1601 TRAPELO ROAD, SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-16
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001610384
Luthringer Remy
C/O MINERVA NEUROSCIENCES, INC.
1601 TRAPELO ROAD, SUITE 286
WALTHAM
MA
02451
1
1
0
0
CEO
Employee Stock Option (right to buy)
0.791
2022-02-16
4
A
0
505000
0.00
A
2032-02-15
Common Stock
505000
505000
D
The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter.
/s/ Ryan Sansom, Attorney-in-Fact
2022-02-18